We are delighted to welcome Stephen Ryan as our new Chief Financial Officer. Stephen has 30 years’ experience in finance, predominantly at CFO/FD level with technology companies. Prior to joining Vitro Software Stephen provided successful interim management solutions to a range of software industry clients. Stephen’s advisory business started after his time as CEO of ADS and previously Head of Finance with CAPE Technologies.

We are delighted to have partnered with CeADAR, Ireland’s Centre for Applied AI. This partnership aligns with our vision of using digital transformation to improve the patient experience and that of the organisations and individuals that care for them. David Nash says "This is an important step for us and our clients, we will start to work with them over the coming year and beyond on projects that enable clients to be more efficient in their operations and ultimately improve the patient experience."

BreastScreen Victoria (BSV) has moved one step closer to full Electronic Records Management by partnering with Vitro Software. The outstanding success of the Vitro pilot has informed the decision to expand the paperless system to the rest of BreastScreen Victoria. “Our clinicians found the software easy to use, and our team found that the time taken to issue written results reduced from 12 days to one or two. The new digital whiteboard has improved patient flow, providing for a better experience for both patients and staff.” said Dr Helen Frazer, Clinical Director at St Vincent’s BreastScreen

Joe Peppard and Colin Waugh join the board of directors. CEO and Chairman David Nash said, “We are delighted to welcome Joe Peppard and Colin Waugh to the board, they are highly accomplished experts who will bring a wealth of experience and insight to the company. They are excited by our vision and drive to use digital transformation to benefit healthcare systems globally. They come at an important juncture as the company looks to grow key areas of the business, including its prebuilt offering Vitro Elements and its cancer screening solution.”